Sign in
CompletedNo phase

Lactoferrin Alone ,Iron Alone Vs Lactoferrin Plus Iron for Treatment of Iron Deficiency Anemia

Key facts

Who runs it
Egymedicalpedia
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
399 people enrolled
Started
10 Jun 2023
Ended
10 Jun 2024
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Lactoferrin
Record updated
19 September 2024

Who can take part

Age
20 years to 35 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Pregnant women with single fetus
  • All pregnant women in 3rd trimester (28w_36w) complaining of mild IDA
  • Iron Deficiency Anemia mild anemia (hemoglobin level < 11 mg/dl , and serum ferritin level < 12 mg/dl)

Who cannot take part

  • Patients with a history of anemia due to any other causes such as chronic blood loss, hemolytic anemia, and thalassemia
  • History of peptic disorders
  • Malabsorption syndrome
  • Clinical and/or laboratory evidence of hepatic, renal, cardiovascular abnormalities
  • Esophagitis
  • Hiatal hernia

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Iron deficiency (ID) and iron deficiency anemia (IDA) are the most common iron disorders throughout the world.

Read full original descriptionShow less

ID and IDA, particularly caused by increased iron requirements during pregnancy; represent a high risk for preterm delivery, fetal growth retardation, low birth weight, and inferior neonatal health. These pregnancy complications are thought to occur because of an increased iron requirement, related to enhanced blood volume and development of the fetoplacental unit.

The 3 groups in the trial

  • Group A: (lactoferrin Group)Existing treatment, for comparison

    About 133 anemic pregnant women will be treated with lactoferrin only (pravotin 100mg ) twice daily for 4 weeks.

    Treatment: Lactoferrin

  • Group B: (Amino acid chelated iron Group)Existing treatment, for comparison

    About 133 anemic pregnant women will be treated with amino acid chelated iron only (phara fero 27) once daily for 4 weeks.

    Treatment: Lactoferrin

  • Group C: (lactoferrin with amino acid chelated iron Group)Existing treatment, for comparison

    About 133 anemic pregnant women will be treated with lactoferrin with amino acid chelated iron (phara fero 27 plus ) once daily for 4 weeks

    Treatment: Lactoferrin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Lactoferrin Alone ,Iron Alone Vs Lactoferrin Plus Iron for Treatment of Iron Deficiency Anemia During the 3rd Trimester of Pregnancy (Randomized Controlled Trial)
Record updated
19 September 2024